EdgarLookup

ZyVersa Therapeutics, Inc.

ZVSA OTC CIK: 0001859007 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 314 filings →
Form Description Date
8-K 8-K Mar 5, 2026
8-K 8-K Dec 3, 2025
8-K 8-K Nov 19, 2025
10-Q 10-Q Nov 19, 2025
NT 10-Q NT 10-Q Nov 14, 2025
8-K 8-K Oct 15, 2025
25-NSE — Oct 6, 2025
8-K 8-K Sep 18, 2025
SCHEDULE 13G/A — Aug 14, 2025
10-Q 10-Q Aug 13, 2025

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Wolfe Peter Chief Financial Officer Award / Grant 3,000 @ $2.88 44,585 Dec 16, 2022
INCON Co., Ltd. — Award / Grant 1,497,199 1,497,199 Dec 12, 2022
Wolfe Peter Chief Financial Officer Award / Grant 41,585 41,585 Dec 12, 2022
LaBella Nicholas A. Jr. Chief Scientific Officer Award / Grant 18,094 18,094 Dec 12, 2022
Glover Stephen C. Chief Executive Officer Award / Grant 43,847 43,847 Dec 12, 2022